Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis
Clinical trial NCT02039687 · COMPLETED
Trial details
- NCT number
- NCT02039687
- Sponsor
- Araim Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.